ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 97 filers reported holding ONCOCYTE CORP in Q3 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,705 | -56.6% | 42,197 | -33.1% | 0.00% | – |
| Q1 2023 | $22,365 | +10.4% | 63,107 | 0.0% | 0.00% | – |
| Q4 2022 | $20,251 | -56.0% | 63,107 | -0.3% | 0.00% | – |
| Q3 2022 | $46,000 | -19.3% | 63,270 | 0.0% | 0.00% | – |
| Q2 2022 | $57,000 | -82.0% | 63,270 | -70.3% | 0.00% | – |
| Q1 2022 | $317,000 | -32.0% | 213,098 | -0.7% | 0.00% | – |
| Q4 2021 | $466,000 | -38.0% | 214,597 | +1.6% | 0.00% | – |
| Q3 2021 | $752,000 | -33.0% | 211,265 | +8.0% | 0.00% | – |
| Q2 2021 | $1,123,000 | +17.8% | 195,676 | +6.6% | 0.00% | – |
| Q1 2021 | $953,000 | +138.2% | 183,500 | +9.6% | 0.00% | – |
| Q4 2020 | $400,000 | +145.4% | 167,382 | +42.5% | 0.00% | – |
| Q3 2020 | $163,000 | -27.2% | 117,495 | 0.0% | 0.00% | – |
| Q2 2020 | $224,000 | +34.1% | 117,495 | +73.2% | 0.00% | – |
| Q1 2020 | $167,000 | +36.9% | 67,843 | +24.9% | 0.00% | – |
| Q4 2019 | $122,000 | +7.0% | 54,338 | 0.0% | 0.00% | – |
| Q3 2019 | $114,000 | -41.2% | 54,338 | -30.1% | 0.00% | – |
| Q2 2019 | $194,000 | +151.9% | 77,719 | +299.1% | 0.00% | – |
| Q1 2019 | $77,000 | -1.3% | 19,473 | +16.0% | 0.00% | – |
| Q4 2017 | $78,000 | -39.5% | 16,783 | -1.6% | 0.00% | – |
| Q3 2017 | $129,000 | +44.9% | 17,052 | -0.1% | 0.00% | – |
| Q2 2017 | $89,000 | +41.3% | 17,075 | +61.5% | 0.00% | – |
| Q1 2017 | $63,000 | – | 10,574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 719,282 | $2,359,245 | 0.35% |
| Defender Capital, LLC. | 114,520 | $357,302 | 0.13% |